Background and Objective. The veno-occlusive disease of the liver (VOD
) is a disorder caused by the non-thrombotic occlusion of the central
veins of hepatic lobules. The clinical features are similar to those o
f intrahepatic portal hypertension (unexplained weight gain, ascites,
painful hepatomegaly, jaundice). In the past, this disease was rather
infrequent and was linked to the absorption of toxic agents, liver irr
adiation or chemotherapy. However, the intensification of treatment pr
otocols before hematopoietic stem cell transplants has considerably in
creased its incidence. The strategies used for its prevention and trea
tment remain limited in efficacy. The present review was undertaken in
order to assess progress in the diagnosis and management of this seve
re complication in stem cell transplantation. Information Sources. The
method used for preparing this review was an examination of 250 relev
ant articles or abstracts published in journals covered by Medline(R).
State of Art. Despite the progress made toward the understanding of i
ts physiopathology and the identification of its risk factors, VOD is
still one of the leading causes of morbidity and mortality during the
first two months post-BMT, and therefore often constitutes a limitatio
n for the further increment of the dose of antineoplastic drugs. This
may be explained by the difficulty in making an early diagnosis of thi
s problem, at a time when therapeutic intervention may be more effecti
ve, and, on the other hand, the lack of a well-established prevention
and treatment approach for patients with VOD. Perspectives and Conclus
ions. New diagnostic procedures, such as laparoscopic liver biopsy, an
d new therapeutic approaches, such as transjugular intrahepatic portos
ystemic shunting (TIPS) or defibrotide, are now being evaluated. Howev
er, additional studies will be needed to determine the most appropriat
e therapy for each VOD patient depending on the severity of the diseas
e. (C) 1997, Ferrata Storti Foundation.